Pathogenesis of Multiple Lentigines in LEOPARD Syndrome with PTPN11 Gene Mutation

被引:20
作者
Motegi, Sei-ichiro [1 ]
Yokoyama, Yoko [1 ]
Ogino, Sachiko [1 ]
Yamada, Kazuya [1 ]
Uchiyama, Akihiko [1 ]
Perera, Buddhini [1 ]
Takeuchi, Yuko [1 ]
Ohnishi, Hiroshi [2 ]
Ishikawa, Osamu [1 ]
机构
[1] Gunma Univ, Dept Dermatol, Grad Sch Med, Maebashi, Gunma 3718511, Japan
[2] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 371, Japan
基金
日本学术振兴会;
关键词
LEOPARD syndrome; SHP-2; multiple lentigines; melanoeyte; mTOR signalling; PROTEIN-TYROSINE-PHOSPHATASE; SHP2; MUTATIONS; HYPERPIGMENTATION; MELANOSOMES; EXPRESSION; MELANOMA; CELLS; WOMAN; MTOR;
D O I
10.2340/00015555-2123
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
LEOPARD syndrome (LS) is an autosomal dominant condition with multiple anomalies, including multiple lentigines. LS is caused by mutations in PTPN11, encoding the protein tyrosine phosphatase, SHP-2. We report here 2 unrelated Japanese cases of LS with different PTPN11 mutations (p.Y279C and p.T468P). To elucidate the pathogenesis of multiple lentigines in LS, ultrastructural and immunohistochemical analyses of lentigines and non-lesional skin were performed. Numerous mature giant melanosomes in melanocytes and keratinocytes were observed in lentigines. In addition, the levels of expression of endothelin-1 (ET-1), phosphorylated Akt, mTOR and STAT3 in the epidermis in lentigines were significantly elevated compared with non-lesional skin. In in vitro assays, melanin synthesis in human melanoma cells expressing SHP-2 with LS-associated mutations was higher than in cells expressing normal SHP-2, suggesting that LS-associated SHP-2 mutations might enhance melanin synthesis in melanocytes, and that the activation of Akt/mTOR signalling may contribute to this process.
引用
收藏
页码:978 / 984
页数:7
相关论文
共 24 条
[1]   GIANT AND GRANULAR MELANOSOMES IN LEOPARD SYNDROME - ULTRASTRUCTURAL-STUDY [J].
BHAWAN, J ;
PURTILO, DT ;
RIORDAN, JA ;
SAXENA, VK ;
EDELSTEIN, L .
JOURNAL OF CUTANEOUS PATHOLOGY, 1976, 3 (05) :207-216
[2]   Scalp melanoma in a woman with LEOPARD syndrome: Possible implication of PTPN11 signaling in melanoma pathogenesis [J].
Cheng, Yu-Pin ;
Chiu, Hsien-Yi ;
Hsiao, Tzu-Lin ;
Hsiao, Cheng-Hsiang ;
Lin, Chia-Chi ;
Liao, Yi-Hua .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (04) :E186-E187
[3]   Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3β Signaling [J].
Edouard, Thomas ;
Combier, Jean-Philippe ;
Nedelec, Audrey ;
Bel-Vialar, Sophie ;
Metrich, Melanie ;
Conte-Auriol, Francoise ;
Lyonnet, Stanislas ;
Parfait, Beatrice ;
Tauber, Maithe ;
Salles, Jean-Pierre ;
Lezoualc'h, Frank ;
Yart, Armelle ;
Raynal, Patrick .
MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (10) :2498-2507
[4]   ACCUMULATION OF MEMBRANE-BOUND MELANOSOMES OCCURS IN LANGERHANS CELLS OF PATIENTS WITH THE LEOPARD SYNDROME [J].
FRYER, PR ;
POPE, FM .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1992, 17 (01) :13-15
[5]   MULTIPLE LENTIGENES SYNDROME [J].
GORLIN, RJ ;
ANDERSON, RC ;
BLAW, M .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1969, 117 (06) :652-&
[6]   Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and enclothelin-1, in ultraviolet B-induced human melanogenesis [J].
Hachiya, A ;
Kobayashi, A ;
Yoshida, Y ;
Kitahara, T ;
Takema, Y ;
Imokawa, G .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (06) :2099-2109
[7]   The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis [J].
Kadono, S ;
Manaka, I ;
Kawashima, M ;
Kobayashi, T ;
Imokawa, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (04) :571-577
[8]   MTOR is activated in the majority of malignant melanomas [J].
Karbowniczek, Magdalena ;
Spittle, Cynthia S. ;
Morrison, Tasha ;
Wu, Hong ;
Henske, Elizabeth P. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (04) :980-987
[9]   PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects [J].
Kontaridis, MI ;
Swanson, KD ;
David, FS ;
Barford, D ;
Neel, BG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) :6785-6792
[10]   PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome [J].
Kosaki, K ;
Suzuki, T ;
Muroya, K ;
Hasegawa, T ;
Sato, S ;
Matsuo, N ;
Kosaki, R ;
Nagai, T ;
Hasegawa, Y ;
Ogata, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3529-3533